BioInformant

Your Global Leader in Stem Cell Market Research

Home » research products

How to find unique market opportunities by stem cell type

By

As the first and only market research firm to specialize in the stem cell industry, BioInformant’s 175-page global strategic report “Stem Cell Research Products – Opportunities, Tools, and Technologies” evaluates strategies across the stem cell product spectrum, with emphasis on opportunities for research product development.

It explores unique market opportunities by stem cell type, including mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), neural stem cells (NSCs), and more. [Read more…]

Global Stem Cell Report Reveals Traditional Metrics, New Social Analytics, and Survey of Stem Cell Scientists

By

One of our most popular market reports is “Stem Cell Research Products – Opportunities, Tools, & Technologies.” It is a 175-page global strategic report that tracks traditional market metrics, which include trend rate data for stem cell clinical trials, scientific publications, grants, patents, product launches, new market entrants, acquisitions, industry deal-making, and more.

Importantly, it also tracks recently discovered social analytics, which are metrics derived from social media sites, search engines, online advertising platforms, and more. Specifically, social analytics can be collected from platforms like Twitter, LinkedIn, Facebook, Google Search, and Google Trends.

The importance of these social analytics is that they reveal both individual user behavior on a topic, as well as aggregate group activity.

[Read more…]

Lonza Reports Strong First Quarter in History in Terms of Sales and Earnings

By

The possibilities arising from stem cells have resulted in great commercial interest, with potential applications ranging from their use in the reversal of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, toxicology assessment, and more. To facilitate research resulting from interest in these potential far-ranging applications, a large and growing stem cells research products market has emerged.

One of several large companies selling stem cell research products is Lonza Group. Others competitors include Thermo Fisher Scientific, BD Biosciences, Merck KGaA, Miltenyi Biotec, STEMCELL Technologies, Clontech (a Takara Bio Company), GE Healthcare Life Sciences, and more.

In major news released today, Lonza Group from Basel, Switzerland, reported a record 1st quarter of 2016, recording its “strongest first quarter in history in terms of sales and earnings.”

Lonza has several different business divisions, including Pharma&Biotech, Specialty Ingredients, Custom Manufacturing, and more. One of these divisions is Lonza Bioscience (LBS), which develops and manufactures tools for life sciences researchers. In this April 26, 2016, press release, Lonza states: “Our healthy Bioscience Solutions business showed further improvement compared with the previous year, driven by product introductions and sound demand in all sub-segments.”

To learn more about Lonza’s role within the research products market, view “Stem Cell Research Products – Opportunities, Tools, and Technologies.

To learn more about Lonza’s record first quarter results, read the full press release issued by Lonza Group (below). [Read more…]

BioInformant Releases “Stem Cell Research Products – Opportunities, Tools, & Technologies” with Market Size, Segments, Trends, & Projections to 2020

By

February 11, 2016; Washington, DC — BioInformant announces the February 2016 release of its global strategic report, “Stem Cell Research Products, Opportunities, Tools, and Technologies” with market size, segments, trends, and projections to 2020.

The first and only market research firm to specialize in the stem cell industry, BioInformant has more than a decade of historical information on all segments of the stem cell market, by stem cell type. This powerful 175 page global strategic report contains market size, segments, trends, and projections through 2020, as well a social analytics and an end-user survey of nearly 300 stem cell scientists. The “Survey of Stem Cell Scientists” identifies technical requirements, unmet needs, and purchasing preferences of stem cell researchers worldwide. [Read more…]

Imagine Increasing Revenue from Stem Cell Products and Decreasing Risk

By

We have helped hundreds of the top companies increase revenue from stem cell products and decrease risk. The key is targeted market intelligence, because it will help you to approach institutional investors for fundraising rounds, guide internal decision-making within your company, and reduce the risk that has traditionally accompanied new product development. Simply put, it will help you make smarter decisions, faster.

Whether or not you can invest in the recently released global strategic report, “Stem Cell Research Products – Opportunities, Tools, and Technologies,” the following is an important introduction to the stem cell research products marketplace, including key trends and future projections. [Read more…]

BioInformant's World-Class Clients